Article
Inflation Expectations Jump To 3 Year High As Financial Pessimism Surges: NY Fed Survey
Inflation Expectations Jump To 3 Year High As Financial Pessimism Surges: NY Fed Survey
Ahead of tomorrow's jobs report which is expected to show a substantial slowdown from last month's 178K surge, moments ago we got another reminder that the stagflationary iceberg remains front and center ahead of the US, after the NY Fed's latest monthly survey of consumer expectations reported that Inflation expectations at the one-year horizon rose again to 3.64% in April from the previous month’s 3.42%, the highest since September 2023. Inflation expectations were unchanged at 3.15% for...
aboutLiberty Portal
Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Apr 4, 2026 / Carlos Boix
The Myth that Won't Die: "War is Good for the Economy"
One of the legacies of Keynesian thought is the belief that war is “good for the economy.” While war may help enable employment, nonetheless, its overall legacy is destructive, and even the jobs war “creates” are economically undesirable.
Read more
May 6, 2026 / Jason Ditz
Israel Kills 16 in Lebanon, Expands Attacks Into Eastern Bekaa Valley
At least 16 more people were killed and dozens of others wounded today as Israel continued its attacks on Lebanon, increasingly stretching the definition of a “ceasefire” which is meant to be in place between the two countries. The largest single incident in the south was in Siksikiyah, where strikes killed five people and wounded […]
Read more
Apr 6, 2026 / Tyler Durden
Big Pharma Forced To Yank COVID Vaxx Study Due To Lack Of Participants
Big Pharma Forced To Yank COVID Vaxx Study Due To Lack Of Participants
Authored by Ben Sellers via Headline USA,
Two of the major pharmaceutical companies connected with the controversial COVID vaccines were forced to abandon a new research study after failing to garner enough participants.
Pfizer and German vax maker BioNTech had sought to research an updated version of the vaccine in adults ages 50 to 64, but were unable to generate the data needed due to the low enrollment in the trials, Reuters reported.
The study was needed in order to meet new guidelines imposed by the Food and Drug Administration that...
Read more




